Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) slows gastric emptying, which changes the rate at which your stomach passes its contents into the intestine. For most medicines this matters very little, but for antidepressants like sertraline, which rely on consistent gut absorption to maintain steady blood levels, the question is worth taking seriously. There is no specific contraindication between tirzepatide and sertraline in the current prescribing literature, but the interaction is not simply zero either — your prescriber needs the full picture before and during treatment. Mounjaro is a prescription-only medicine; a clinician decides whether it is suitable for you.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The mechanism behind this question is worth understanding clearly. Tirzepatide activates both GIP and GLP-1 receptors in the gut, and one of the results is that the stomach empties more slowly than usual. That is partly why people feel fuller for longer on Mounjaro. The side effect on absorption, though, is that medicines you swallow pass through the stomach more gradually, which can shift the time it takes to reach peak concentration in the blood.
Sertraline is taken orally and absorbed in the small intestine. Its therapeutic effect depends on maintaining relatively stable plasma levels day to day. A meaningful delay in gastric emptying could, in theory, blunt or shift the absorption curve. The practical consequence varies between individuals, some people notice nothing; others may find that their antidepressant feels subtly different, especially in the early weeks of Mounjaro or after moving up a dose. The BNF's tirzepatide monograph flags this class effect as something prescribers should consider for all oral medicines with a narrow therapeutic index or time-sensitive absorption, and sertraline sits in that category.
This is not a reason to avoid Mounjaro if you take sertraline. It is a reason to have the conversation before you start, and to keep having it as your dose increases. If you are curious how this sits alongside other interactions people ask about, the fuller guide to Mounjaro and sertraline covers this ground in more detail.
There is a second thread here that goes beyond pharmacokinetics. You are likely reading this because you are already managing your mental health carefully (sertraline is not something people take casually) and adding a new medicine to that picture is not a small decision. That caution is entirely reasonable.
Weight-loss treatment can have real psychological effects too. Some people experience improved mood as their health and confidence shift; others find that the appetite suppression, nausea or disrupted eating patterns that come with early Mounjaro use affect how they feel day to day. If your sertraline levels are simultaneously fluctuating because of slower gastric emptying, disentangling those effects becomes harder. Your GP and any mental health team involved in your care should know you are starting tirzepatide, and a named prescriber (not a software tool) should be able to see the full list of medicines you take before approving treatment. The tirzepatide overview on this site explains how clinical review works in practice.
The NHS medicines page for tirzepatide lists low mood and self-harm thoughts among the side effects to watch for, separate from the sertraline question. Report any of these urgently to a clinician.
Getting this right comes down to a few concrete actions, not vague reassurances. First, list every medicine you take (prescribed, over-the-counter, and any supplements) when you complete your consultation. Sertraline should be front and centre of that list. Second, let your GP know you are starting a GLP-1 medicine; GP notification is part of how clinically responsible services handle this. Asking your GP or mental health prescriber to keep a closer eye on how your sertraline is working in the first few months is sensible.
Third, track your own mood with some deliberateness in the first weeks. If sertraline has been stable for a while and suddenly feels less effective, or if anxiety increases, that is worth reporting. The same applies to any GI side effects that might affect how consistently you are absorbing your antidepressant. Vomiting shortly after taking sertraline, for instance, is a simple but overlooked reason why a tablet may not have worked that day.
If you are comparing how Mounjaro affects different aspects of health and daily life, the page on Mounjaro and HRT addresses a similar absorption concern for oestrogen, and the question of Mounjaro and periods covers how hormonal shifts during weight loss can complicate the picture further. For people managing ADHD medicines alongside tirzepatide, this page on tirzepatide and ADHD tackles an overlapping concern about oral medication absorption.
The cost of treatment is a real consideration too. If you want to understand what private Mounjaro treatment involves financially, the Mounjaro price comparison sets out what honest private pricing should look like, which helps you assess any service before handing over your health history.
Some situations need prompt attention rather than watching and waiting. Contact a doctor or call 111 if you notice a sudden or significant change in mood, increased suicidal thoughts, or a feeling that your sertraline has stopped working within a short period of starting Mounjaro or increasing your dose. Seek urgent help for severe or persistent stomach pain (especially pain that moves towards the back) as this can signal pancreatitis, a known but infrequent serious effect of GLP-1 medicines flagged in a January 2026 MHRA Drug Safety Update.
You can also report a suspected interaction or side effect via the MHRA Yellow Card scheme. Reports from patients are taken seriously and contribute to ongoing safety monitoring for newer medicines like tirzepatide.
Our clinical team reviews every consultation personally and considers your complete medicine list before any treatment is approved. If you want a prescriber to assess whether Mounjaro is right for you alongside sertraline, the place to start is a free, no-obligation consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.